ELTROMBOPAG 75 mg/1

Eltrombopag 75 mg tablets are a medication used to support platelet production in certain medical conditions. This oral treatment is designed to help manage low platelet counts, often associated with chronic conditions.

Eltrombopag is primarily used to increase platelet production in individuals with chronic conditions that affect platelet levels. It is often prescribed for conditions where the body does not produce enough platelets, which are essential for blood clotting. This medication is taken orally and works by stimulating the bone marrow to produce more platelets.

Common effects of Eltrombopag may include mild gastrointestinal discomfort, such as nausea or diarrhea. Some individuals might experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Eltrombopag should be handled with care, especially by individuals with liver conditions, as it can affect liver function. It is important to follow the prescribed dosage and not to exceed it without medical advice. Regular monitoring of liver function may be recommended during treatment.

Eltrombopag can interact with certain medications, particularly those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be moderated, as it can exacerbate potential side effects.